Impact of HLA-DQA1*05 Genotype in Immunogenicity and Failure to Treatment with Tumour Necrosis Factor-alpha Antagonists in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Leticia Rodríguez-AlcoladoElena Grueso-NavarroÁngel AriasAlfredo J LucendoEmilio José Laserna-MendietaPublished in: Journal of Crohn's & colitis (2024)
HLA-DQA1*05 carriage may be associated with an increased risk of immunogenicity and secondary LOR in IBD patients treated with TNF-a antagonists.